Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Ketamine, a drug introduced in the 1960s as an anesthetic agent and still used for that purpose, has garnered marked interest over the past two decades as an emerging treatment for major depressive disorder. With increasing evidence of its efficacy in treatment-resistant depression and its potential...
Saved in:
Main Authors: | Dmitriy Matveychuk (Author), Rejish K. Thomas (Author), Jennifer Swainson (Author), Atul Khullar (Author), Mary-Anne MacKay (Author), Glen B. Baker (Author), Serdar M. Dursun (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression
by: Raymond Yan, et al.
Published: (2024) -
Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
by: Hai-Xia Chang, et al.
Published: (2023) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013) -
Corrigendum: Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
by: Hai-Xia Chang, et al.
Published: (2023) -
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine's Rapid Antidepressant Actions
by: Lauren Wegman-Points, et al.
Published: (2020)